ORTEXORTEX News
Tracking ECG? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EC
Earnings PreviewECG

ECG Surges Into Earnings as Peers Slide

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 4 Nov 2026, 04:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ECG heads into its November 4 print on a sharp divergence from the rest of its sector, up 9.5% on the day and 10.8% on the week while most close peers have sold off.

The contrast with the peer group is stark. FIX fell 3.5% on the week, IESC dropped 9.6%, STRL lost 7%, and LGN slid 1.7%. ECG's move higher runs against that current, suggesting the market is positioning around the earnings release itself rather than tracking sector sentiment. Options traders are not especially defensive: the put/call ratio of 0.20 is running slightly below its 20-day average of 0.22, a mild lean toward calls rather than puts, though the z-score of -0.82 means this is barely outside normal. The lending market shows no short pressure either. Availability has loosened sharply over recent weeks, reaching 4,652% from a trough near 2,000% in mid-October, meaning shares to borrow far outnumber those already borrowed. Short interest, at 3.9% of the free float, has risen about 18% over the past month but borrowing costs have eased to 0.35%, their lowest level in the period shown.

The bull and bear cases divide cleanly along segment lines. Bulls point to the Electrical and Mechanical segment, where data center and semiconductor project demand has driven the backlog to a record $4.55 billion, up 53% year on year, with the company guiding for 80% conversion within 12 months. Guggenheim raised its target to $184 after the August print, and Oppenheimer holds at $185. EPS momentum is strong, ranking in the 93rd percentile on a 90-day basis and 83rd on 30 days, with an EPS surprise score in the 88th percentile. Against that, Cantor Fitzgerald trimmed its target to $152 after the same August print, citing the Transmission and Distribution segment, where master service agreement work accounts for 50% to 60% of revenue but sits outside the backlog and constrains margin visibility. Customer concentration adds to the caution: the top 10 clients contributed 43% of 2025 revenues, with one at roughly 17%. Note that analyst data shown here is from August and may not reflect subsequent views. The mean target of $176 implies roughly 56% upside from Monday's close of $112.73, though the gap warrants caution given the data's age.

Institutional ownership has been building. BlackRock added roughly 503,000 shares to reach 12.9% of the company as of September 30. Invesco added 553,000 shares over the same period to reach 2.4%. On the insider side, the most recent open-market purchase was director David Sparby buying 1,000 shares at $144.95 in August, though net insider activity over the prior 90 days was modestly negative, driven by a VP sale of around $451,000 in early August. The two most recent earnings reactions offer limited pattern guidance: a 5.5% one-day decline followed August's print, while the prior release saw a 2.5% gain. Neither move persisted significantly into the following week.

The print will test whether the record backlog and E&M momentum can justify ECG's sharp pre-earnings rally at a time when most of its peers have moved in the opposite direction.

Stocks in this article

See the live data behind this article on ORTEX.

Open ECG on ORTEX →

How this article was generated

Generated
4 Nov 2026, 04:42
Data as of
4 Nov 2026, 04:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.